百洋医药(301015)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301015 百洋医药

交易中 05-21 10:53:00

{"stockData":{"symbol":"301015","market":"SZ","secType":"STK","nameCN":"百洋医药","latestPrice":33.99,"timestamp":1716259980000,"preClose":33.16,"halted":0,"volume":2562697,"delay":0,"floatShares":119000000,"shares":526000000,"eps":1.3316,"marketStatus":"交易中","marketStatusCode":2,"change":0.83,"latestTime":"05-21 10:53:00","open":33.17,"high":34.3,"low":32.59,"amount":86231900,"amplitude":0.0516,"askPrice":34,"askSize":42,"bidPrice":33.99,"bidSize":47,"shortable":0,"etf":0,"ttmEps":1.3316,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1716262200000},"adr":0,"adjPreClose":33.16,"symbolType":"stock","openAndCloseTimeList":[[1716255000000,1716262200000],[1716267600000,1716274800000]],"highLimit":36.48,"lowLimit":29.84,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":525613491,"pbRate":6.37,"roa":"--","roe":"6.03%","epsLYR":1.25,"committee":-0.226804,"marketValue":17866000000,"floatMarketCap":4041000000,"peRate":25.525684,"changeRate":0.025,"turnoverRate":0.0216,"status":0},"requestUrl":"/m/hq/s/301015","defaultTab":"news","newsList":[{"id":"2436124272","title":"百洋医药最新公告：拟8.8亿元收购百洋制药60.199%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2436124272","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2436124272?lang=zh_cn&edition=full","pubTime":"2024-05-20 16:31","pubTimestamp":1716193861,"startTime":"0","endTime":"0","summary":"百洋医药公告，公司拟通过收购百洋制药、百洋投资、百洋伊仁和百洋康合的股权进而持有上海百洋制药股份有限公司（简称“百洋制药”）共60.199%的股权，总交易价格为8.8亿元。交易完成后，百洋医药控制百洋制药61.794%股权，直接或间接方式持有百洋制药共60.199%的股权，是百洋制药的控股股东。百洋制药的主要业务为中成药、化学仿制药产品的研发、生产及销售。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052000015525.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435633026","title":"百洋医药：公司运营的功效型护肤品有艾思诺娜、传皙诺、仙人掌、可复美等，销售状况良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2435633026","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435633026?lang=zh_cn&edition=full","pubTime":"2024-05-15 19:01","pubTimestamp":1715770863,"startTime":"0","endTime":"0","summary":"证券之星消息，百洋医药05月15日在投资者关系平台上答复投资者关心的问题。请问到现在为止，有具体的投向公司吗？本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500031809.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430679227","title":"百洋医药：公司运营的泌特、安斯泰来系列等产品销售状况良好，符合公司全年预期目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2430679227","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430679227?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:01","pubTimestamp":1714129299,"startTime":"0","endTime":"0","summary":"投资者：公司2023年年报未提及泌特系列，安斯泰来系列，罗氏制药的肿瘤创新药产品及罗盖全等产品的销售情况，请问上述产品的销售情况？百洋医药董秘：投资者您好，2023年度公司运营紫晟收入约4400万，占公司品牌运营业务收入较少，对公司业绩影响较小，谢谢！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600047499.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430118904","title":"百洋医药（301015）4月24日主力资金净卖出1506.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430118904","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430118904?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:22","pubTimestamp":1714008166,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月24日收盘，百洋医药报收于30.04元，下跌1.02%，换手率5.57%，成交量6.63万手，成交额1.98亿元。近5日资金流向一览见下表：百洋医药融资融券信息显示，融资方面，当日融资买入691.48万元，融资偿还1072.01万元，融资净偿还380.54万元。百洋医药主营业务：为医药产品生产企业提供商业化整体解决方案,包括提供医药产品的品牌运营、批发配送及零售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500018286.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429749441","title":"中国银河：给予百洋医药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429749441","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429749441?lang=zh_cn&edition=full","pubTime":"2024-04-24 10:46","pubTimestamp":1713926803,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司程培,孙怡近期对百洋医药进行研究并发布了研究报告《业务结构持续优化，利润保持高增速》，本报告对百洋医药给出买入评级，当前股价为29.77元。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为40.51。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400023139.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429122328","title":"【机构调研记录】弘毅远方基金调研恒逸石化、百洋医药等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2429122328","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429122328?lang=zh_cn&edition=full","pubTime":"2024-04-24 08:02","pubTimestamp":1713916940,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月23日披露的机构调研信息，弘毅远方基金近期对3家上市公司进行了调研，相关名单如下：1）恒逸石化 个股亮点：恒逸转2于2022-08-18上市,恒逸转债于2020-11-16上市；公司分别与阿里云、西门子形成战略合作伙伴，助力公司生产管理从业务驱动向数据驱动升级，完成智能化经营决策与预测，提升公司综合竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400013913.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429125015","title":"百洋医药（301015）2024年一季报简析：净利润增35.6%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2429125015","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429125015?lang=zh_cn&edition=full","pubTime":"2024-04-24 06:22","pubTimestamp":1713910960,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期百洋医药发布2024年一季报。根据财报显示，本报告期中百洋医药净利润增35.6%，盈利能力上升。截至本报告期末，公司营业总收入16.61亿元，同比下降1.5%，归母净利润1.66亿元，同比上升35.6%。重仓百洋医药的前十大基金见下表：持有百洋医药最多的基金为工银前沿医疗股票A，目前规模为108.53亿元，最新净值2.835，较上一交易日上涨0.64%，近一年下跌17.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400012269.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429118406","title":"百洋医药：4月23日接受机构调研，天风证券、青骊投资等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2429118406","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429118406?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:54","pubTimestamp":1713880487,"startTime":"0","endTime":"0","summary":"百洋医药2024年一季报显示，公司主营收入16.61亿元，同比下降1.5%；归母净利润1.66亿元，同比上升35.6%；扣非净利润1.65亿元，同比上升30.71%；负债率50.3%，投资收益842.38万元，财务费用1097.09万元，毛利率29.75%。该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为40.51。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300042760.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429162147","title":"百洋医药(301015.SZ)拟5000万元参投阿斯利康中金青岛医疗健康创投基金 投资医疗健康领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2429162147","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429162147?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:29","pubTimestamp":1713868177,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百洋医药 公告，公司与阿斯利康商务咨询(无锡)有限公司、中金资本运营有限公司、山东省新动能基金管理有限公司、青岛市创新投资有限公司、青岛市引导基金投资有限公司、青岛高新产业发展母基金合伙企业、无锡阿斯利康中金创业投资合伙企业、济南高新财金投资有限公司、银丰融金(北京)投资管理有限公司、津市嘉山产业发展投资有限公司共同出资设立阿斯利康中金青岛医疗健康创业投资基金(暂定名)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107703.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429742989","title":"图解百洋医药一季报：第一季度单季净利润同比增35.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429742989","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429742989?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:35","pubTimestamp":1713807327,"startTime":"0","endTime":"0","summary":"证券之星消息，百洋医药2024年一季报显示，公司主营收入16.61亿元，同比下降1.5%；归母净利润1.66亿元，同比上升35.6%；扣非净利润1.65亿元，同比上升30.71%；负债率50.3%，投资收益842.38万元，财务费用1097.09万元，毛利率29.75%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300002084.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429104059","title":"百洋医药最新公告：一季度净利润1.66亿元 同比增长35.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429104059","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429104059?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:10","pubTimestamp":1713777027,"startTime":"0","endTime":"0","summary":"百洋医药公布2024年一季度报告，报告期营业收入16.61亿元，同比下降1.50%；归属于上市公司股东的净利润1.66亿元，同比增长35.60%；归属于上市公司股东的扣除非经常性损益的净利润1.65亿元，同比增长30.71%；基本每股收益0.3158元。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200019826.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429912342","title":"百洋医药(301015.SZ)发布2023年度业绩，净利润6.56亿元，增长29.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912342","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429912342?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:39","pubTimestamp":1713775170,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百洋医药(301015.SZ)发布2023年年度报告，报告期内，公司实现营业收入75.64亿元，同比增长0.72%。实现归属于上市公司股东的净利润6.56亿元，同比增长29.55%。实现归属于上市公司股东的扣除非经常性损益的净利润6.35亿元，同比增长25.14%。基本每股收益为1.25元。拟向全体股东每10股派发现金红利7.62元(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106492.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429291402","title":"百洋医药(301015.SZ)发布一季度业绩，净利润1.66亿元，增长35.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429291402","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429291402?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:37","pubTimestamp":1713775043,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百洋医药(301015.SZ)发布2024年一季度报告，报告期内实现营业收入16.61亿元，同比下降1.50%。归属于上市公司股东的净利润1.66亿元，同比增长35.60%。归属于上市公司股东的扣除非经常性损益的净利润1.65亿元，同比增长30.71%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106490.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2390827314","title":"百洋医药(301015.SZ)拟斥4950万元与专业投资机构共同投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2390827314","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2390827314?lang=zh_cn&edition=full","pubTime":"2023-12-10 17:23","pubTimestamp":1702200180,"startTime":"0","endTime":"0","summary":"百洋医药发布公告，为实现产业战略布局，把握战略合作机会，充分借助专业合作伙伴的投资管理、运营管理经验、优质资源和专业能力，促进公司产业延展升级和资产优化扩大，青岛百洋医药股份有限公司拟与北京百洋众信康健投资管理有限公司、百洋医药集团有限公司、北京市门头沟区京西产业引导基金、北京中关村高精尖创业投资基金共同出资设立北京市门头沟百洋医药产业投资基金。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-10/doc-imzxprfw5312817.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-10/doc-imzxprfw5312817.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-06-30","address":"山东省青岛市市北区开封路88号","stockEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.003},{"period":"3month","weight":0.0567},{"period":"6month","weight":-0.1573},{"period":"1year","weight":0.2919},{"period":"ytd","weight":-0.0753}],"companyName":"青岛百洋医药股份有限公司","boardCode":"AI0051","perCapita":"16146股","boardName":"批发业","registeredCapital":"52561万元","compareEarnings":[{"period":"1week","weight":0.0073},{"period":"1month","weight":0.0345},{"period":"3month","weight":0.085},{"period":"6month","weight":0.0419},{"period":"1year","weight":-0.0342},{"period":"ytd","weight":0.066}],"survey":"　　青岛百洋医药股份有限公司是专业的医药产品商业化平台，主营业务是为医药产品生产企业提供商业化整体解决方案，包括提供医药产品的品牌运营、批发配送及零售，致力于成为连接医药产品和下游消费者的纽带，为品牌医药生产企业提供产品营销的综合解决方案。","serverTime":1716259984095,"listedPrice":7.64,"stockholders":"7363人(较上一季度减少6.24%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百洋医药(301015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百洋医药(301015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百洋医药,301015,百洋医药股票,百洋医药股票老虎,百洋医药股票老虎国际,百洋医药行情,百洋医药股票行情,百洋医药股价,百洋医药股市,百洋医药股票价格,百洋医药股票交易,百洋医药股票购买,百洋医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百洋医药(301015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百洋医药(301015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}